A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer.
about
Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerRecent progress in pancreatic cancerPerspectives in the treatment of pancreatic adenocarcinomaEfficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic ReviewBorderline resectable pancreatic cancerA multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.Neoadjuvant strategies for pancreatic cancerNeoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer.Improving outcomes in pancreatic cancer: key points in perioperative managementS-1 in the treatment of pancreatic cancer.Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates?Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationshipsNeoadjuvant therapy of pancreatic cancer: the emerging paradigm?Robotic radiosurgery in pancreatic cancer: A systematic review.Update on the Management of Pancreatic Cancer in Older Adults.Neoadjuvant treatment for resectable pancreatic adenocarcinoma.Meta-analyses of treatment standards for pancreatic cancer.Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC).Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinicalManagement options in locally advanced pancreatic cancer.Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.The role of neoadjuvant therapy in pancreatic cancer: a review.Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis.Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases.Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.Inferior Infracolic 'Superior Mesenteric Artery First' Approach with a No-Touch Isolation Surgical Technique in Patients with a Borderline Resectable Cancer of the Pancreatic Head.Importance of resectability status in neoadjuvant treatment for pancreatic cancer.Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort studyRole of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-BiliaNeoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection.Response assessment in pancreatic ductal adenocarcinoma: role of imaging.Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma.RETRACTED: Pre-treatment DWI as a predictor of overall survival in locally advanced pancreatic cancer treated with Cyberknife radiotherapy and sequential S-1 therapy.Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.Role of radiotherapy in the chemotherapy-containing multidisciplinary management of patients with resected pancreatic adenocarcinoma.Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer.Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.
P2860
Q24194621-4724CF3D-0710-4CC3-A402-0200BB726912Q24626346-924C1D5F-F283-4949-9E3B-B43556B6596AQ26797248-FD3C2B61-DF7B-4DE5-A444-96D083143C39Q28079611-13318F9B-F466-45F3-AB9C-E837664D2CFAQ28081596-00733267-D993-44CD-9559-0E0CD5E8A8DFQ33408075-87D01D89-43D5-4CA7-8C60-3A26975C30EEQ33948343-FAF4E3F9-EDB9-48D8-B468-5BC9D394E5BAQ34357427-AC12CE62-A7D6-4154-AFE4-68B6F3D2FBDDQ34366880-B54F6B81-A25A-4C82-9618-FB94832712BCQ34467156-0C9D57B4-78EE-4447-81FC-40AD4F12ABEFQ34892858-A12BA33B-6CD2-46BB-B6F9-1B60C8FA1C98Q35155573-0364FE0A-FD4E-40A3-8BAD-912C7D409F5CQ35776229-521DFE4E-2DA6-4F26-AA16-E602633CA755Q35970200-89E3BACA-5D91-4457-99E4-8872427CF0D2Q36095529-84EF28CF-8458-4000-A501-24791A927BD9Q36526141-B855D40E-8BC0-4C7D-A474-56815AA0CA37Q36640493-FAE668AF-A3D7-4098-A232-0C3D462FB04DQ36792347-F1612941-305B-4935-B200-FCFDE799252BQ37403232-408DA503-D31A-4983-9165-449605E75200Q37431673-4B6063EF-107B-413C-80AC-2FBC7ADE5EA1Q37517051-F7F1CA6E-9828-4492-918C-D48E47EDC970Q38205127-2DE56815-0E0E-40DA-A171-1AF2922BE4BBQ38212152-06BAD8AB-C2DB-4DA3-B165-0D5C9EC3A333Q38734981-5E7E8AC0-B315-46C8-992D-EA6737A435D8Q38907944-AB9F8D50-8103-44A5-80EC-56346B70394DQ39302032-FA5DBB13-9D91-447D-AC9D-D475DEEE090BQ39338280-5CA3DB14-16A9-499D-84D6-CA9BAA16B9B2Q39417424-CBD969CB-E598-4182-B63D-5E585E06C174Q41002447-34646270-0EAD-474A-8705-1F8FCBE18F4FQ41545288-988AA1C5-BEC6-4620-822D-3941CDBC890CQ43502366-66D52174-0991-48A6-8BDB-CD7E4E385BAFQ47750487-15BD2733-B36D-4B11-93CE-57FF88514BADQ48113453-4A80C5E8-E776-48B7-BB98-A365F5E1808BQ49072822-2CFB861A-A632-4159-BFF5-9294C6276762Q50300787-4C4F39E4-F72D-430D-BDBF-640B4861D17EQ50558607-E74A1079-1AC5-41D4-B9C0-F5F17AA4F9B6Q52873316-F6C2DE9E-B812-4DCD-9D66-E8CECF88694FQ52991088-AA775AF2-16BE-4DDC-B9D4-57457B2DF735Q55634822-1D6DE6A1-1BAE-40F8-AE8B-44211D7BAD0A
P2860
A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A systematic review and meta-a ...... therapy for pancreatic cancer.
@ast
A systematic review and meta-a ...... therapy for pancreatic cancer.
@en
A systematic review and meta-a ...... therapy for pancreatic cancer.
@nl
type
label
A systematic review and meta-a ...... therapy for pancreatic cancer.
@ast
A systematic review and meta-a ...... therapy for pancreatic cancer.
@en
A systematic review and meta-a ...... therapy for pancreatic cancer.
@nl
prefLabel
A systematic review and meta-a ...... therapy for pancreatic cancer.
@ast
A systematic review and meta-a ...... therapy for pancreatic cancer.
@en
A systematic review and meta-a ...... therapy for pancreatic cancer.
@nl
P2093
P2860
P1476
A systematic review and meta-a ...... therapy for pancreatic cancer.
@en
P2093
Charbel Sandroussi
Guy D Eslick
Jerome Martin Laurence
Kavita Morarji
Peter Duy Tran
Vincent Wai To Lam
P2860
P2888
P304
P356
10.1007/S11605-011-1659-7
P577
2011-09-13T00:00:00Z